In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Masashi DemuraDepartment of Hygiene, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
Takashi YonedaDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Shigehiro KarashimaDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.ORCID 0000-0002-4084-9653 Mitsuhiro KometaniDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.ORCID 0000-0003-0461-3018 Daisuke AonoDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Seigo KonishiDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.
Shin-Ichi HorikeDivision of Functional Genomics, Research Center for Experimental Modeling of Human Disease, 13-1 Takara-machi, Kanazawa 920-8640, Japan.ORCID 0000-0002-4256-9129 Yasuhiro NakamuraDivision of Pathology, Tohoku Medical and Pharmaceutical University 1-15-1 Fukumuro, Miyaginoku, Sendai 983-8536, Japan.
Yuto YamazakiDepartment of Pathology, Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Yoshiyu TakedaDepartment of Health Promotion and Medicine of Future, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan.ORCID 0000-0002-5670-8871 Funding
Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (B) 21790889
6 · The paper itselfAbstract
Indexed as
Cytochrome P-450 CYP11B2DNA MethylationPheochromocytomaPromoter Regions, GeneticSteroid 11-beta-HydroxylaseAdrenal Gland NeoplasmsAdrenal MedullaAdultAgedCpG IslandsEpigenesis, GeneticEpigenomicsFemaleHumansMaleMiddle AgedCytochrome P-450 CYP11B2Steroid 11-beta-Hydroxylaseadrenal medullaadrenal zonationCYP11B1CYP11B2DNA methylation
Identifiers
PMID39596027
PMCPMC11593487
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390